| Literature DB >> 8869939 |
Abstract
Improvement in supportive care including the introduction of new antibiotics, antiviral and antifungal agents and haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infection during neutropenia is still a major complication and a great concern for the clinician responsible for the patient. Management of infectious complications in the neutropenic patient is reviewed.Entities:
Mesh：
Substances：
Year: 1996 PMID： 8869939 DOI： 10.1007/bf02988841
Source DB: PubMed Journal: Med Oncol ISSN： 1357-0560 Impact factor: 3.064